Literature DB >> 20569258

Revealing the human mutome.

J M Chen1, C Férec, D N Cooper.   

Abstract

The number of known mutations in human nuclear genes, underlying or associated with human inherited disease, has now exceeded 100,000 in more than 3700 different genes (Human Gene Mutation Database). However, for a variety of reasons, this figure is likely to represent only a small proportion of the clinically relevant genetic variants that remain to be identified in the human genome (the 'mutome'). With the advent of next-generation sequencing, we are currently witnessing a revolution in medical genetics. In particular, whole-genome sequencing (WGS) has the potential to identify all disease-causing or disease-associated DNA variants in a given individual. Here, we use examples of recent advances in our understanding of mutational/pathogenic mechanisms to guide our thinking about possible locations outwith gene-coding sequences for those disease-causing or disease-associated variants that are likely so often to have been overlooked because of the inadequacy of current mutation screening protocols. Such considerations are important not only for improving mutation-screening strategies but also for enhancing the interpretation of findings derived from genome-wide association studies, whole-exome sequencing and WGS. An improved understanding of the human mutome will not only lead to the development of improved diagnostic testing procedures but should also improve our understanding of human genome biology.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20569258     DOI: 10.1111/j.1399-0004.2010.01474.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

Review 1.  Deafness in the genomics era.

Authors:  A Eliot Shearer; Michael S Hildebrand; Christina M Sloan; Richard J H Smith
Journal:  Hear Res       Date:  2011-10-08       Impact factor: 3.208

Review 2.  Hyperparathyroid genes: sequences reveal answers and questions.

Authors:  Stephen J Marx
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

Review 3.  Revisiting Mendelian disorders through exome sequencing.

Authors:  Chee-Seng Ku; Nasheen Naidoo; Yudi Pawitan
Journal:  Hum Genet       Date:  2011-02-18       Impact factor: 4.132

4.  Single-variant and multi-variant trend tests for genetic association with next-generation sequencing that are robust to sequencing error.

Authors:  Wonkuk Kim; Douglas Londono; Lisheng Zhou; Jinchuan Xing; Alejandro Q Nato; Anthony Musolf; Tara C Matise; Stephen J Finch; Derek Gordon
Journal:  Hum Hered       Date:  2013-04-11       Impact factor: 0.444

5.  Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era.

Authors:  Nadine Norton; Peggy D Robertson; Mark J Rieder; Stephan Züchner; Evadnie Rampersaud; Eden Martin; Duanxiang Li; Deborah A Nickerson; Ray E Hershberger
Journal:  Circ Cardiovasc Genet       Date:  2012-02-15

6.  Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project.

Authors:  Leslie G Biesecker
Journal:  Genet Med       Date:  2012-02-16       Impact factor: 8.822

Review 7.  Human genetics and genomics a decade after the release of the draft sequence of the human genome.

Authors:  Nasheen Naidoo; Yudi Pawitan; Richie Soong; David N Cooper; Chee-Seng Ku
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

8.  A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases.

Authors:  Miao-Xin Li; Hong-Sheng Gui; Johnny S H Kwan; Su-Ying Bao; Pak C Sham
Journal:  Nucleic Acids Res       Date:  2012-01-12       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.